1. Home
  2. NEUE vs VNRX Comparison

NEUE vs VNRX Comparison

Compare NEUE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • VNRX
  • Stock Information
  • Founded
  • NEUE 2015
  • VNRX N/A
  • Country
  • NEUE United States
  • VNRX United States
  • Employees
  • NEUE N/A
  • VNRX N/A
  • Industry
  • NEUE
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • NEUE
  • VNRX Health Care
  • Exchange
  • NEUE NYSE
  • VNRX Nasdaq
  • Market Cap
  • NEUE 60.7M
  • VNRX 56.5M
  • IPO Year
  • NEUE 2021
  • VNRX N/A
  • Fundamental
  • Price
  • NEUE $7.35
  • VNRX $0.55
  • Analyst Decision
  • NEUE Hold
  • VNRX Strong Buy
  • Analyst Count
  • NEUE 1
  • VNRX 4
  • Target Price
  • NEUE $7.00
  • VNRX $4.17
  • AVG Volume (30 Days)
  • NEUE 19.3K
  • VNRX 103.1K
  • Earning Date
  • NEUE 03-06-2025
  • VNRX 03-24-2025
  • Dividend Yield
  • NEUE N/A
  • VNRX N/A
  • EPS Growth
  • NEUE N/A
  • VNRX N/A
  • EPS
  • NEUE N/A
  • VNRX N/A
  • Revenue
  • NEUE $996,890,000.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • NEUE N/A
  • VNRX $71,446.31
  • Revenue Next Year
  • NEUE $9.44
  • VNRX N/A
  • P/E Ratio
  • NEUE $2.16
  • VNRX N/A
  • Revenue Growth
  • NEUE N/A
  • VNRX 97.50
  • 52 Week Low
  • NEUE $3.79
  • VNRX $0.43
  • 52 Week High
  • NEUE $11.35
  • VNRX $1.10
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 61.05
  • VNRX 41.65
  • Support Level
  • NEUE $7.30
  • VNRX $0.56
  • Resistance Level
  • NEUE $7.66
  • VNRX $0.61
  • Average True Range (ATR)
  • NEUE 0.07
  • VNRX 0.04
  • MACD
  • NEUE -0.05
  • VNRX -0.00
  • Stochastic Oscillator
  • NEUE 26.19
  • VNRX 2.67

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: